Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Finasteride can treat hair loss, but may have side effects; evaluate and inform patients of risks.

The surgical technique of scalp advancement and pretrichial brow lift shortens the forehead and lifts brows, is good for women and transgender women with high foreheads, but not recommended for men and has some risks.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Megasessions in hair transplant can cover more area or increase density but need a skilled team and careful planning, and have both benefits like less downtime and risks like lower graft survival.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Some dermatology patients in Turkey use traditional medicine, with herbal remedies being most common, but these treatments can have mixed results and risks.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

Tamsulosin may slightly increase dementia risk compared to other treatments for enlarged prostate.

Male relatives of women with PCOS show similar health issues, suggesting a male version of the condition.

Dutasteride reduces DHT more effectively than finasteride.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Certain genetic variants may increase the risk of developing PCOS.

H1 increases risk for neurodegenerative diseases, while H2 offers protection but is linked to other disorders.

Long working hours increase the risk of hair loss in Korean male workers.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Finasteride does not increase the risk of depression or suicide.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.